CCS
TEVA icon

Concentric Capital Strategies’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Concentric Capital Strategies’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.24M Buy
+66,030
New +$2.2M 0.12% 164
2024
Q3 		– Sell
-75,856
Closed -$1.23M – 380
2024
Q2 		$1.23M Buy
+75,856
New +$1.17M 0.06% 239

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Concentric Capital Strategies's TEVA Position: Q2 2026 in Review

Concentric Capital Strategies opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026: 66,030 shares worth $2.24M. The stake represents 0.12% of the portfolio and ranks #164 among its holdings. This is a return to the name: Concentric Capital Strategies previously reported a position in TEVA as recently as Q2 2024.

Concentric Capital Strategies first reported a position in TEVA in Q2 2024 and has held it in 2 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Concentric Capital Strategies held 66,030 shares of Teva Pharmaceutical Industries Limited worth $2.24M as of Q2 2026.
  • Teva Pharmaceutical Industries Limited was a new Concentric Capital Strategies position in Q2 2026.
  • Teva Pharmaceutical Industries Limited made up 0.12% of Concentric Capital Strategies's portfolio in Q2 2026, its #164 holding.
  • Concentric Capital Strategies first reported a position in Teva Pharmaceutical Industries Limited in Q2 2024 and has held it in 2 quarters since.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Concentric Capital Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.